← Back to guidelines
Endocrinology143 papers

Hypothalamic-pituitary-adrenal axis dysfunction

Last edited: 4/15/2026

Overview

Hypothalamic-pituitary-adrenal (HPA) axis dysfunction involves abnormal regulation of cortisol production, often characterized by either hyperactivity or suppression of the axis, impacting various physiological processes 12.

Diagnosis

  • Measure baseline ACTH and cortisol levels to assess HPA axis function.
  • Stimulate with CRH to evaluate dynamic responses in ACTH and cortisol secretion 1.
  • Monitor urinary-free cortisol levels over time to assess recovery and persistent suppression 1.
  • Consider pulsatile secretion patterns in glucocorticoid dynamics, though specific diagnostic tests are not detailed 2.
  • Management

  • For glucocorticoid suppression, monitor and manage with dose adjustments or temporary cessation of exogenous glucocorticoids if applicable.
  • No specific first-line treatments mentioned for general HPA axis dysfunction; focus on underlying cause 12.
  • Adjunctive therapies may include stress management and lifestyle modifications to support HPA axis recovery 2.
  • Special Populations

  • Pregnancy: No specific data provided in the abstracts.
  • Pediatrics: No specific data provided in the abstracts.
  • Elderly: No specific data provided in the abstracts.
  • Comorbidities: No specific data provided in the abstracts regarding comorbidities 12.
  • Key Recommendations

  • Monitor serum and urinary cortisol levels following interventions like epidural glucocorticoid injections to assess HPA axis suppression and recovery (Evidence: Moderate) 1.
  • Consider pulsatile dynamics of glucocorticoid secretion in understanding HPA axis function and dysfunction (Evidence: Expert opinion) 2.
  • Tailor management strategies to address underlying causes of HPA axis dysfunction rather than applying blanket treatments (Evidence: Expert opinion) 12.
  • References

    1 Iranmanesh A, Gullapalli D, Singh R, Veldhuis JD. Hypothalamo-pituitary-adrenal axis after a single epidural triamcinolone injection. Endocrine 2017. link 2 Spiga F, Walker JJ, Gupta R, Terry JR, Lightman SL. 60 YEARS OF NEUROENDOCRINOLOGY: Glucocorticoid dynamics: insights from mathematical, experimental and clinical studies. The Journal of endocrinology 2015. link

    Original source

    1. [1]
      Hypothalamo-pituitary-adrenal axis after a single epidural triamcinolone injection.Iranmanesh A, Gullapalli D, Singh R, Veldhuis JD Endocrine (2017)
    2. [2]
      60 YEARS OF NEUROENDOCRINOLOGY: Glucocorticoid dynamics: insights from mathematical, experimental and clinical studies.Spiga F, Walker JJ, Gupta R, Terry JR, Lightman SL The Journal of endocrinology (2015)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG